Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

alsdkjfaslfjasldfajsdalfasfdl September 2018 Dear Valued Customer: It is with heavy hearts that we are reaching out to you about the devastation caused by Hurricane Florence. In the aftermath of this powerful storm, our thoughts remain with all of those impacted, as does our steadfast commitment to help them during this challenging time. To ensure that …
Presented at IASLC 2018 World Conference on Lung Cancer in Toronto, Canada
Sturm - Federal Health Policy_August 2018 Update_463588 Date Federal Health Policy: How It May Affect Your Program September 21, 2018 Association of Community Cancer Centers Oncology Reimbursement Meeting 1 Agenda 0100.015\463588(pptx)-E2 9-21-18 BackgroundI. Drug Pricing TrendsII. 340B Drug Pricing ProgramIII. Oncology Care Model (OCM)IV. New Reimbursement …
2018 ACCC Institute for the Future of Oncology Reflect, Renew, Reignite: Creating a Resilient Oncology Team in Your Community EXECUTIVE SUMMARY Each year, the ACCC Institute for the Future of Oncology brings together key leaders in the oncology community in a one-day forum discussion focused on significant issues in cancer care delivery they are facing today, and those they are …
In this guest blog post, learn how 2018 ACCC Innovator Award recipient Ochsner Health System, Ochsner Cancer Institute of New Orleans is helping cancer patients access early-phase clinical trials close to home. Age-adjusted mortality rates from cancer are higher in Louisiana than the national average. Every day, 70 Louisianans receive a cancer diagnosis, and 23 Louisianans die of cancer. In April …
INTEGRATION OF PATHOLOGY IN ONCOLOGY CARE LEADERSHIP SUMMIT July 31, 2018 Washington, D.C. EXECUTIVE SUMMARY Integration of Pathology in Oncology Care Leadership Summit – Executive Summary 1 Introduction The role of pathology in the diagnosis and management of cancer has changed in a new era of precision medicine and rapidly progressing cancer therapies. Advances in molecular …
Thank You to Our 2024 Corporate Members! The ESHOS Board and Membership would like to express appreciation for our Corporate Members and industry affiliates, who play a vital role in the success of our programs and the strength of the society. Corporate Membership runs from January 1st - December 31st each year. To learn more about partnering with ESHOS as a Corporate Member, please review our benefits …
ACCC 2018 Innovator Award Winner Sidney Kimmel Cancer Center at Jefferson Health in Philadelphia, PA, has implemented new tools and processes to deliver a proactive, multidisciplinary team approach to caring for patients on cancer immunotherapies via continuous symptom monitoring and effective management of immune-related adverse events. Guest blogger Tracy Virgilio, RN, MSN, CCRC, OCN, describes the …
FINANCIAL TOXICITY Financial Toxicity Navigation Process Improvement Improving patient flow by optimizing EHRs BY N ATA S H A G O M E S Finances are often a major concern for patients dealing with a cancer diagnosis. In 2017 DuPage Medical Group, Downers Grove, Ill., directed more attention and resources toward our financial navigation department to assist patients in minimizing …
Hundreds of oncology professionals will gather for this “how-to” conference to hear innovative strategies for enhancing program operations, addressing gaps in care delivery, tackling real-world challenges, and supporting a culture of well-being for the entire multidisciplinary care team. What: Association of Community Cancer Centers 35th National Oncology Conference When: October 17–19, 2018 …
A forthright conversation between the treating clinician, patient and family members on the importance of self-reporting adverse events must take place prior to consideration of combination immunotherapy.
Focusing on the patient experience led this ACCC 2018 Innovator Award recipient to create a new approach to caring for patients with advanced cancer receiving radiation therapy for symptom palliation. Learn about Mount Sinai Hospital’s Palliative Radiation Oncology Consult service in this guest blog post by Kavita Dharmarajan, MD, MSc, assistant professor of radiation oncology and palliative medicine …
Immune-related adverse events (irAEs) are a complex category of symptoms driven by anti-cancer immunotherapy treatments. The use of IO has burgeoned since the approval of ipilimumab in 2011 through multiple approvals of anti-PD-1/PD-L1 drugs and most recently CAR-T therapies, and so too has the number of recognized irAEs.
Survivorship care planning requires communication, care coordination, and education. Since immune-related adverse events are still being discovered, these discussions are even more imperative.
INTEGRATION OF PATHOLOGY IN ONCOLOGY CARE LEADERSHIP SUMMIT July 31, 2018 Washington, D.C. EXECUTIVE SUMMARY Integration of Pathology in Oncology Care Leadership Summit – Executive Summary 1 Introduction The role of pathology in the diagnosis and management of cancer has changed in a new era of precision medicine and rapidly progressing cancer therapies. Advances in molecular …
Microsoft Word - 12618637_2.DOCX 1 \\DC - 099654/000003 - 12618637 v2 September 10, 2018 Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Ave., SW Washington, DC 20201 BY ELECTRONIC DELIVERY Re: Medicare Program; Revisions to Payment Policies Under the Physician Fee …
Research nurse Joannne Riemer, RN, BSN, started her position at Johns Hopkins Medical Institution in 2010. Within six months, she was working with checkpoint inhibitors. From her vantage point in clinical trials research, she discusses the many changes in IO clinical trials patient selection over the last eight years.
Thank You to Our 2024 Corporate Members! The RMOS Board and Membership would like to express appreciation for our Corporate Members and industry affiliates, who play a vital role in the success of our programs and the strength of the society. Corporate Membership runs from January 1st - December 31st each year. To learn more about partnering with RMOS as a Corporate Member, please review our benefits …
Nearly four months have passed since the Trump Administration released its blueprint for lowering drug prices. In the intervening time, there has been scrutiny of administration discussion on implementation of various proposals outlined in the plan. Most recently, during the month of August the Centers for Medicare & Medicaid Services (CMS) used its authority to the fullest, releasing two policy …
The University of North Carolina (UNC), North Carolina Cancer Hospital was the first program in the nation to adopt a closed-system transfer device that has saved $39 million in drug expense annually by reducing waste. This 2018 ACCC Innovator Award recipient will describe the process behind drug vial optimization at the ACCC 35th National Oncology Conference in October. In this guest blog post, Lindsey …